Leif Gunnar Håkansson
Amministratore Delegato presso CanImGuide Therapeutics AB
Posizioni attive di Leif Gunnar Håkansson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | - | - | |
| Direttore Tecnico/Scientifico/R&S | - | - | |
| Fondatore | - | - |
Storia della carriera di Leif Gunnar Håkansson
Precedenti posizioni note di Leif Gunnar Håkansson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | Corporate Officer/Principal | - | - |
| University of Lund | Corporate Officer/Principal | - | - |
Formazione di Leif Gunnar Håkansson
| University of Lund | Doctorate Degree |
Statistiche
Distribuzione geografica
| Svezia | 4 |
Posizioni
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
